Pathogen Inactivation of Cellular Blood Products – More Security for the Patient or Less?

Publisher： Karger

E-ISSN： 1660-3818|30|6|261-263

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.30, Iss.6, 2003-12, pp. : 261-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Concerning Caspari et al: Pathogen Inactivation of Cellular Blood Products – More Security for the Patient or Less? Transfus Med Hemother 2003;30:261–263

By  

Transfusion Medicine and Hemotherapy, Vol. 32, Iss. 1, 2005-01 ,pp. : 45-48

Karger

Access to resources Recommend Favorite

Pathogen Inactivation of Cellular Blood Products – Still Plenty of Reason to Be Careful

By  

Transfusion Medicine and Hemotherapy, Vol. 32, Iss. 5, 2005-09 ,pp. : 258-260

Karger

Access to resources Recommend Favorite

Pathogen Inactivation Technologies for Cellular Blood Components: an Update

By  

Transfusion Medicine and Hemotherapy, Vol. 41, Iss. 4, 2014-07 ,pp. : 309-325

Karger

Access to resources Recommend Favorite

Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 33-42

Karger

Access to resources Recommend Favorite

Meeting the Challenges of Blood Safety in the 21st Century: Pathogen Inactivation

By  

Transfusion Medicine and Hemotherapy, Vol. 31, Iss. 1, 2004-02 ,pp. : 1-

Karger

Access to resources Recommend Favorite